FDA 483 - Azazuddin A. Ahmed, MD - November 30, 2015

Azazuddin A. Ahmed, MD, a clinical investigator in Chicago, IL, received an FDA Form 483 with two observations following an inspection. The observations detail failures to furnish complete investigational progress reports to drug study sponsors and to ensure proper IRB review and approval for clinical studies. These findings indicate significant deficiencies in the conduct and oversight of clinical trials.